An error in Figure 1 led to the misrepresentation of the trial design in this figure. The 541 patients enrolled in the study were randomly assigned to three different arms rather than just to a single arm (oseltamivir-zanamivir combination) as suggested by the published figure. - 192 patients were assigned oseltamivir-zanamivir and included in intention to treat analysis - 176 were assigned oseltamivir-placebo and included in intention to treat analysis - 173 were assigned zanamivir-placebo and included in intention to treat analysis See the Corrected Figure 1 via the link below:
Footnotes
No competing interests declared.
